Publikationen
Weitere Informationen zu den Publikationen der AG Prof. Sippl finden sie hier:
2026
Riepenhausen L, Sarnow AC, Robaa D, Sippl W. AI-Based Prediction of PROTAC- and Molecular Glue-Mediated Ternary Complexes: A Comparative Evaluation of AlphaFold 3 and Boltz-2. .Arch Pharm (Weinheim). 2026 Mar;359(3):e70225. doi:10.1002/ardp.70225
Gimenez Borges L, Alves TNO, Vassiliades SV, Carlos JAEG, Waitman KB, Hilscher S, Schutkowski M, Sippl W, Tavares MT, Toledo MFZJ, Costa-Lotufo LV, Kronenberger T, Machado-Neto JA, Parise-Filho R. Capsaicin-Inspired Hydroxamate Hybrids as Selective HDA6 Inhibitors with Antiproliferative Activity in Hematological Malignancies. ACS Omega. 2026 Jan 28;11(5):8415-8430. doi:10.1021/acsomega.5c11286 .
Tanyi SA, Eni DB, Abdelsalam M, Tjegbe MJM, Schmidt M, Ndip RN, Tietjen I, Sippl W, Ntie-Kang F. Fragment-Based Design of Pseudo-Natural Products, Synthesis, and Evaluation of Their HIV-1 Latency-Reversing Properties. Chem Biol Drug Des. 2026 Feb;107(2):e70235. doi:10.1111/cbdd.70235 .
Erdogan A, Tirpanlar D, Gungor B, Gurdal EE, Sippl W, Aru B, Yanikkaya Demirel G, Koksal M. Design, synthesis and evaluation of novel oxadiazole-based compounds as potential Rac1 inhibitors against breast cancer. Eur J Med Chem. 2026 Feb 5;303:118396. doi:10.1016/j.ejmech.2025.118396 .
Betow JY, Qaseem A, Bekono BD, Feng Y, Moumbock AFA, Simoben CV, Babiaka SB, Tanyi SA, Shu VA, Ndi AT, Onguéné PA, Metuge CS, Akame S, Eni DB, Namba-Nzanguim CT, Tjegbe MJM, Dikande MNL, Akeh PT, Balgah S Jr, Meh CD, Ibezim A, Tabi IF, Malange YI, Ndingkokhar B, Njume LE, Telukunta KK, Amrani S, Ebob OT, Sippl W, Günther S, Ntie-Kang F. African Natural Products Database (ANPDB): A Resource for Exploring the Therapeutic Potential of Natural Compounds from Africa. Nucleic Acids Res. 2026 Jan 6;54(D1):D1336-D1344. doi:10.1093/nar/gkaf1186.